Home >> Signaling Pathways >> Apoptosis

Apoptosis

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

What is Apoptosis? The Apoptotic Pathways and the Caspase Cascade

Targets for  Apoptosis

Products for  Apoptosis

  1. Cat.No. Product Name Information
  2. GC43274 Citromycetin Citromycetin is a fungal metabolite originally isolated from P. Citromycetin  Chemical Structure
  3. GC63393 Citronellyl acetate Citronellyl acetate is a monoterpene product of the secondary metabolism of plants, with antinociceptive activity. Citronellyl acetate  Chemical Structure
  4. GC52367 Citrullinated Vimentin (G146R) (R144 + R146) (139-159)-biotin Peptide A biotinylated and citrullinated mutant vimentin peptide Citrullinated Vimentin (G146R) (R144 + R146) (139-159)-biotin Peptide  Chemical Structure
  5. GC52370 Citrullinated Vimentin (R144) (139-159)-biotin Peptide A biotinylated and citrullinated vimentin peptide Citrullinated Vimentin (R144) (139-159)-biotin Peptide  Chemical Structure
  6. GN10219 Ciwujianoside-B Ciwujianoside-B  Chemical Structure
  7. GC64649 Cjoc42 Cjoc42 is a compound capable of binding to gankyrin. Cjoc42 inhibits gankyrin activity in a dose-dependent manner. Cjoc42 prevents the decrease in p53 protein levels normally associated with high amounts of gankyrin. Cjoc42 restores p53-dependent transcription and sensitivity to DNA damage. Cjoc42  Chemical Structure
  8. GC39485 CK2/ERK8-IN-1 A dual inhibitor of CK2 and ERK8 CK2/ERK8-IN-1  Chemical Structure
  9. GC49556 Cl-Necrostatin-1 A RIPK1 inhibitor Cl-Necrostatin-1  Chemical Structure
  10. GC47098 CL2-SN-38 (dichloroacetic acid salt) An antibody-drug conjugate containing SN-38 CL2-SN-38 (dichloroacetic acid salt)  Chemical Structure
  11. GC60714 CL2A-SN-38 An antibody-drug conjugate containing SN-38 CL2A-SN-38  Chemical Structure
  12. GC52469 CL2A-SN-38 (dichloroacetic acid salt) An antibody-drug conjugate containing SN-38 CL2A-SN-38 (dichloroacetic acid salt)  Chemical Structure
  13. GC10509 Cladribine Apoptosis inducer in CLL cells Cladribine  Chemical Structure
  14. GC60111 Clitocine Clitocine, an adenosine nucleoside analog isolated from mushroom, is a potent and efficacious readthrough agent. Clitocine acts as a suppressor of nonsense mutations and can induce the production of p53 protein in cells harboring p53 nonsense-mutated alleles. Clitocine can induce apoptosis in multidrug-resistant human cancer cells by targeting Mcl-1. Anticancer activity. Clitocine  Chemical Structure
  15. GC15219 Clofarabine Antimetabolite,inhibit DNA polymerase and ribonucleotide reductase Clofarabine  Chemical Structure
  16. GC10813 Clofibric Acid PPAR agonist Clofibric Acid  Chemical Structure
  17. GC32587 Clofilium tosylate Clofilium tosylate, a potassium channel blocker, induces apoptosis of human promyelocytic leukemia (HL-60) cells via Bcl-2-insensitive activation of caspase-3. Clofilium tosylate  Chemical Structure
  18. GC47105 Clonostachydiol A fungal metabolite with anticancer and anthelmintic activities Clonostachydiol  Chemical Structure
  19. GC12367 CM-272 CM-272 is a first-in-class reversible dual inhibitor against G9a and DNMTs with IC50 values of 8 nM and 382 nM, respectively [1]. CM-272  Chemical Structure
  20. GC62347 CMC2.24 CMC2.24 (TRB-N0224), an orally active tricarbonylmethane agent, is effective against pancreatic tumor in mice by inhibiting Ras activation and its downstream effector ERK1/2 pathway. CMC2.24  Chemical Structure
  21. GC61567 CMLD-2 CMLD-2, an inhibitor of HuR-ARE interaction, competitively binds HuR protein disrupting its interaction with adenine-uridine rich elements (ARE)-containing mRNAs (Ki=350 nM). CMLD-2 induces apoptosis exhibits antitumor activity in different cancer cells as colon, pancreatic, thyroid and lung cancer cell lines. Hu antigen R (HuR) is an RNA binding protein, can regulate target mRNAs stability and translation. CMLD-2  Chemical Structure
  22. GC49096 Cobaltic Protoporphyrin IX (chloride) An inducer of HO-1 activity Cobaltic Protoporphyrin IX (chloride)  Chemical Structure
  23. GC10033 Cobimetinib A potent, orally available MEK1 inhibitor Cobimetinib  Chemical Structure
  24. GC43297 Coenzyme Q2 Coenzyme Q10 is a component of the electron transport chain and participates in aerobic cellular respiration, generating energy in the form of ATP. Coenzyme Q2  Chemical Structure
  25. GC62192 COG1410 COG1410 is an apolipoprotein E-derived peptide. COG1410  Chemical Structure
  26. GC40664 Colcemid Colcemid is a cytoskeletal inhibitor that induces mitotic arrest in the G2/M phase or meiotic arrest in the vesicle rupture (GVBD) phase in mammalian cells or oocytes, respectively. Colcemid  Chemical Structure
  27. GN10123 Columbianadin Columbianadin  Chemical Structure
  28. GC49454 Complex 3 A fluorescent copper complex with anticancer activity Complex 3  Chemical Structure
  29. GC18572 Concanavalin A

    Concanamycin A belongs to the concanamycins, a family of macrolide antibiotics isolated from Streptomyces diastatochromogenes that are highly active and selective inhibitors of the vacuolar proton-ATPase (v-[H+]ATPase).

    Concanavalin A  Chemical Structure
  30. GC18832 Conglobatin Conglobatin is a dimeric macrolide dilactone originally isolated from S. Conglobatin  Chemical Structure
  31. GC48483 Conglobatin B A bacterial metabolite Conglobatin B  Chemical Structure
  32. GC48497 Conglobatin C1 A bacterial metabolite Conglobatin C1  Chemical Structure
  33. GC38376 Coniferaldehyde Coniferaldehyde (Ferulaldehyde) is an effective inducer of heme oxygenase-1 (HO-1). Coniferaldehyde  Chemical Structure
  34. GC63379 Conophylline Conophylline is a vinca alkaloid extracted from leaves of a tropical plant Ervatamia microphylla. Conophylline  Chemical Structure
  35. GC16772 Cortisone acetate Glucocorticoid receptor agonist Cortisone acetate  Chemical Structure
  36. GC16116 Costunolide A natural sesquiterpene lactone Costunolide  Chemical Structure
  37. GC15225 COTI-2 activates mutant forms of p53 COTI-2  Chemical Structure
  38. GC15840 CP 31398 dihydrochloride A p53 stabilizing agent CP 31398 dihydrochloride  Chemical Structure
  39. GC13091 CP-724714 HER2 inhibitor,potent and selective CP-724714  Chemical Structure
  40. GC14500 CPI-1189 necrosis factor (TNF) alpha inhibitor CPI-1189  Chemical Structure
  41. GC14699 CPI-203 BET bromodomain inhibitor CPI-203  Chemical Structure
  42. GC10021 CPI-360 EZH2 inhibitor CPI-360  Chemical Structure
  43. GC14921 CPI-613 An inhibitor of α-ketoglutarate dehydrogenase CPI-613  Chemical Structure
  44. GC39365 CPTH2 CPTH2 is a potent histone acetyltransferase (HAT) inhibitor. CPTH2 selectively inhibits the acetylation of histone H3 by Gcn5. CPTH2 induces apoptosis and decreases the invasiveness of a clear cell renal carcinoma (ccRCC) cell line through the inhibition of acetyltransferase p300 (KAT3B). CPTH2  Chemical Structure
  45. GC35747 Crebanine Crebanine, an alkaloid from Stephania venosa, induces G1 arrest and apoptosis in human cancer cells. Crebanine  Chemical Structure
  46. GC34543 cRIPGBM cRIPGBM, a proapoptotic derivative of RIPGBM, a cell type-selective inducer of apoptosis in GBM cancer stem cells (CSCs) by binding to receptor-interacting protein kinase 2 (RIPK2), with an EC50 of 68 nM in GBM-1 cells. cRIPGBM  Chemical Structure
  47. GC13838 CRT 0066101 PKD inhibitor CRT 0066101  Chemical Structure
  48. GC35750 CRT0066101 dihydrochloride CRT0066101 dihydrochloride is a potent and specific PKD inhibitor with IC50 values of 1, 2.5 and 2 nM for PKD1, 2, and 3 respectively. CRT0066101 dihydrochloride  Chemical Structure
  49. GC45414 CRT0066854   CRT0066854  Chemical Structure
  50. GC14355 CRT5 PKD1, PKD2, and PKD3 inhibitor CRT5  Chemical Structure
  51. GC32911 CTX1 CTX1 is a p53 activator that overcomes HdmX-mediated p53 repression. CTX1 exhibits potent anti-cancer activity in a mouse acute myeloid leukemia (AML) model system. CTX1  Chemical Structure
  52. GN10535 Cucurbitacin B Cucurbitacin B  Chemical Structure
  53. GC35758 Cucurbitacin IIa Cucurbitacin IIa is a triterpene isolated from Hemsleya amalils Diels, induces apoptosis of cancer cells, reduces expression of survivin, reduces phospho-Histone H3 and increases cleaved PARP in cancer cells. Cucurbitacin IIa  Chemical Structure
  54. GN10788 Cucurbitacin IIb Cucurbitacin IIb  Chemical Structure
  55. GC32781 CUDC-427 (GDC-0917) CUDC-427 (GDC-0917) is a potent second-generation pan-selective IAP antagonist, used for treatment of various cancers. CUDC-427 (GDC-0917)  Chemical Structure
  56. GC12115 CUDC-907 A dual inhibitor of HDACs and PI3Ks CUDC-907  Chemical Structure
  57. GC11217 CUR 61414 potent inhibitor of hedgehog-induced cellular activity CUR 61414  Chemical Structure
  58. GC14787 Curcumin A yellow pigment with diverse biological activities Curcumin  Chemical Structure
  59. GC40226 Curcumin-d6 Curcumin-d6 is intended for use as an internal standard for the quantification of curcumin by GC- or LC-MS. Curcumin-d6  Chemical Structure
  60. GN10521 Curcumol Curcumol  Chemical Structure
  61. GC66356 Cusatuzumab Cusatuzumab is a human αCD70 monoclonal antibody. Cusatuzumab shows cytotoxicity activity with enhanced antibody-dependent cellular. Cusatuzumab reduces leukemia stem cells (LSCs) and triggers gene signatures related to myeloid differentiation and apoptosis. Cusatuzumab has the potential for the research of Acute myeloid leukemia (AML). Cusatuzumab  Chemical Structure
  62. GC63967 Cycleanine Cycleanine is a potent vascular selective Calcium antagonist. Cycleanine  Chemical Structure
  63. GC49716 Cyclo(RGDyK) (trifluoroacetate salt) A cyclic peptide ligand of αVβ3 integrin Cyclo(RGDyK) (trifluoroacetate salt)  Chemical Structure
  64. GC17198 Cycloheximide

    Cycloheximide is an antibiotic that inhibits protein synthesis at the translation level, acting exclusively on cytoplasmic (80s) ribosomes of eukaryotes.

    Cycloheximide  Chemical Structure
  65. GC43346 Cyclopamine-KAAD Cyclopamine-KAAD, a hedgehog signaling inhibitor, is a smoothened antagonist. Cyclopamine-KAAD  Chemical Structure
  66. GC47148 Cyclophosphamide-d4 An internal standard for the quantification of cyclophosphamide Cyclophosphamide-d4  Chemical Structure
  67. GC38419 Cyclovirobuxine D An alkaloid with diverse biological activities Cyclovirobuxine D  Chemical Structure
  68. GC33330 Cynaropicrin A sesquiterpene lactone Cynaropicrin  Chemical Structure
  69. GC65565 Cyproheptadine Cyproheptadine is a potent and orally active 5-HT2A receptor antagonist, with antidepressant and antiserotonergic effects. Cyproheptadine  Chemical Structure
  70. GC33779 Cysteamine (β-Mercaptoethylamine) Cysteamine (β-Mercaptoethylamine)  Chemical Structure
  71. GC13502 Cysteamine HCl Cysteamine HCl (2-Aminoethanethiol hydrochloride) is an orally active agent for the treatment of nephropathic cystinosis and an antioxidant. Cysteamine HCl  Chemical Structure
  72. GC17050 CYT387 A potent inhibitor of JAK1 and JAK2 CYT387  Chemical Structure
  73. GC11383 CYT997 (Lexibulin) CYT997 (Lexibulin) (CYT-997) is a potent and orally active tubulin polymerisation inhibitor with IC50s of 10-100 nM in cancer cell lines; with potent cytotoxic and vascular disrupting activity in vitro and in vivo. CYT997 (Lexibulin) induces cell apoptosis and induces mitochondrial ROS generation in GC cells. CYT997 (Lexibulin)  Chemical Structure
  74. GC13070 Cytarabine Cytotoxic agent, blocks DNA synthesis Cytarabine  Chemical Structure
  75. GC43356 CytoCalcein™ Violet 450 CytoCalcein? Violet 450 is a fluorogenic dye used to assess cell viability. CytoCalcein™ Violet 450  Chemical Structure
  76. GC43357 CytoCalcein™ Violet 500 CytoCalcein? Violet 500 is a fluorogenic dye used to assess cell viability. CytoCalcein™ Violet 500  Chemical Structure
  77. GC43361 Cytostatin (sodium salt) Cytostatin is a natural antitumor inhibitor of cell adhesion to extracellular matrix, blocking adhesion of B16 melanoma cells to laminin and collagen type IV in vitro (IC50s = 1.3 and 1.4 μg/ml, respectively) and B16 cells metastatic activity in mice. Cytostatin (sodium salt)  Chemical Structure
  78. GC43368 D,L-1′-Acetoxychavicol Acetate D,L-1′-Acetoxychavicol acetate is a natural compound first isolated from the rhizomes of ginger-like plants. D,L-1′-Acetoxychavicol Acetate  Chemical Structure
  79. GC66824 D-α-Tocopherol Succinate D-α-Tocopherol Succinate (Vitamin E succinate) is an antioxidant tocopherol and a salt form of vitamin E. D-α-Tocopherol Succinate inhibits Cisplatin -induced cytotoxicity. D-α-Tocopherol Succinate can be used for the research of cancer. D-α-Tocopherol Succinate  Chemical Structure
  80. GC12256 D-Mannitol osmotic diuretic agent,weak renal vasodilator. D-Mannitol  Chemical Structure
  81. GC60796 D-Trimannuronic acid D-Trimannuronic acid, an alginate oligomer is extracted from seaweed. D-Trimannuronic acid  Chemical Structure
  82. GC13202 D4476 Inhibitor of CK1 and ALK5 D4476  Chemical Structure
  83. GC17851 D609 A competitive inhibitor of PC-specific PLC D609  Chemical Structure
  84. GC50296 D9 D9 is a potent and selective inhibitor of thioredoxin reductase (TrxR), with an EC50 of 2.8 nM. D9 has the capability to inhibit tumor proliferation both in vitro and in vivo. D9  Chemical Structure
  85. GC18421 Dabcyl-YVADAPV-EDANS Dabcyl-YVADAPV-EDANS is a fluorogenic substrate for caspase-1. Dabcyl-YVADAPV-EDANS  Chemical Structure
  86. GC47166 Dabrafenib-d9 An internal standard for the quantification of dabrafenib Dabrafenib-d9  Chemical Structure
  87. GC14485 Dacarbazine Antineoplastic( malignant melanoma and sarcomas) Dacarbazine  Chemical Structure
  88. GC47167 Dacarbazine-d6 An internal standard for the quantification of dacarbazine Dacarbazine-d6  Chemical Structure
  89. GC68305 Dacetuzumab Dacetuzumab  Chemical Structure
  90. GC10225 Dacomitinib (PF299804, PF299) Dacomitinib (PF299804, PF299) (PF-00299804) is a specific and irreversible inhibitor of the ERBB family of kinases with IC50s of 6 nM, 45.7 nM and 73.7 nM for EGFR, ERBB2, and ERBB4, respectively. Dacomitinib (PF299804, PF299)  Chemical Structure
  91. GC15211 Damnacanthal p56lck tyrosine kinase inhibitor Damnacanthal  Chemical Structure
  92. GN10318 Danshensu Danshensu  Chemical Structure
  93. GC34010 Danshensu (Dan shen suan A)

    Danshensu, an active ingredient of Salvia miltiorrhiza, shows wide cardiovascular benefit by activating Nrf2 signaling pathway.

    Danshensu (Dan shen suan A)  Chemical Structure
  94. GC15217 Danusertib (PHA-739358) A pan-Aurora kinase and Abl inhibitor Danusertib (PHA-739358)  Chemical Structure
  95. GC17650 DAPK Substrate Peptide A DAPK1 peptide substrate DAPK Substrate Peptide  Chemical Structure
  96. GC49883 DAPK Substrate Peptide (trifluoroacetate salt) A DAPK1 peptide substrate DAPK Substrate Peptide (trifluoroacetate salt)  Chemical Structure
  97. GC12942 DAPT (GSI-IX)

    Inhibitor of γ-secretase

    DAPT (GSI-IX)  Chemical Structure
  98. GC43379 Darinaparsin A dimethylated arsenic linked to glutathione Darinaparsin  Chemical Structure
  99. GC15568 Dasatinib (BMS-354825) An inhibitor of Abl and Src Dasatinib (BMS-354825)  Chemical Structure
  100. GC35812 Dasatinib hydrochloride A potent and dual AblWT/Src inhibitor Dasatinib hydrochloride  Chemical Structure
  101. GC10354 Daunorubicin HCl Daunorubicin (Daunomycin) hydrochloride is a topoisomerase II inhibitor with potent anti-tumor activity. Daunorubicin HCl  Chemical Structure

Items 601 to 700 of 2215 total

per page
  1. 5
  2. 6
  3. 7
  4. 8
  5. 9

Set Descending Direction